GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
2.680
0.00 (0.00%)
At close: Jan 16, 2026, 4:00 PM EST
2.700
+0.020 (0.75%)
After-hours: Jan 16, 2026, 7:42 PM EST
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $909.68 million as of January 16, 2026. Its market cap has decreased by -49.16% in one year.
Market Cap
909.68M
Enterprise Value
1.18B
1-Year Change
-49.16%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $909.68M, a decrease of -92.82%. That is a compound annual growth rate of -39.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 909.68M | -1.11% |
| Dec 31, 2025 | 919.86M | -48.59% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |